President and CEO of BioMimetic Therapeutics Inc. (BMTI, Financial) Samuel Eugene Lynch sells 9,000 shares of BMTI on 09/24/2009 at an average price of $13.03 a share.
Biomimetic Therapeutics Inc. has a market cap of $282.5 million; its shares were traded at around $12.99 with and P/S ratio of 89.7.
Recent Trades of BioMimetic Therapeutics Inc. by CEO:
Recent Trades of BioMimetic Therapeutics Inc. by CFO:
Recent Trades of BioMimetic Therapeutics Inc. by Directors and Officers:
Recent Trades of BioMimetic Therapeutics Inc. by CEO:
- Sell: President and CEO Samuel Eugene Lynch sold 6,000 shares of BMTI stock on 09/10/2009 at the average price of $12; the price of the stock has increased by 8.25% since.
- Sell: President and CEO Samuel Eugene Lynch sold 6,000 more shares of BMTI stock on 08/26/2009 at the average price of $11.59; the price of the stock has increased by 12.08% since.
- Sell: President and CEO Samuel Eugene Lynch sold 6,000 more shares of BMTI stock on 08/13/2009 at the average price of $10.82; the price of the stock has increased by 20.06% since.
- Sell: President and CEO Samuel Eugene Lynch sold 3,000 more shares of BMTI stock on 07/30/2009 at the average price of $10.09; the price of the stock has increased by 28.74% since.
- Sell: President and CEO Samuel Eugene Lynch sold 3,000 more shares of BMTI stock on 07/29/2009 at the average price of $9.84; the price of the stock has increased by 32.01% since.
Recent Trades of BioMimetic Therapeutics Inc. by CFO:
- Buy: CFO Lawrence E Bullock bought 6,000 shares of BMTI stock on 04/01/2009 at the average price of $6.8; the price of the stock has increased by 91.03% since.
Recent Trades of BioMimetic Therapeutics Inc. by Directors and Officers:
- Buy: Director James G Murphy bought 508 shares of BMTI stock on 06/25/2009 at the average price of $8.5; the price of the stock has increased by 52.82% since.
- Buy: 10% Owner A/s Novo bought 343,406 shares of BMTI stock on 06/25/2009 at the average price of $8.5; the price of the stock has increased by 52.82% since.
- Buy: Director Gary E Friedlaender bought 8,174 shares of BMTI stock on 06/25/2009 at the average price of $8.5; the price of the stock has increased by 52.82% since.
- Buy: Director Christopher B Ehrlich bought 941,177 shares of BMTI stock on 04/07/2009 at the average price of $8.5; the price of the stock has increased by 52.82% since.
